Sep 17, 2026 07:00AM
Sep 17, 2026 07:00AM
Sep 1, 2026 07:00AM
Aug 11, 2026 04:01PM
Aug 11, 2026 04:01PM
Aug 10, 2026 07:02AM
Aug 10, 2026 07:00AM Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm™ (dibutepinephrine) Sublingual Film
Jul 29, 2026 07:00AM
May 15, 2026 04:50AM
May 13, 2026 04:01PM
May 12, 2026 09:31AM
May 12, 2026 09:31AM
May 6, 2026 07:00AM
Mar 30, 2026 07:00AM Aquestive completes FDA meeting on Anaphylm drug application
Mar 30, 2026 07:00AM
Mar 20, 2026 07:00AM
Mar 20, 2026 07:00AM
Mar 20, 2026 07:00AM
Mar 19, 2026 09:00AM
Mar 17, 2026 09:00AM
Mar 13, 2026 09:00AM AQST Shareholder Alert: May 4, 2026 Lead Plaintiff Deadline in Aquestive Therapeutics, Inc. Securities Class Action Lawsuit — The Gross Law Firm
Mar 11, 2026 07:01PM
Mar 10, 2026 09:00AM
Mar 9, 2026 04:01PM
Mar 6, 2026 04:40AM
Mar 4, 2026 04:01PM
Feb 20, 2026 07:00AM
Feb 18, 2026 07:00AM Aquestive Therapeutics names Matthew Greenhawt as chief medical officer
Feb 18, 2026 07:00AM
Feb 3, 2026 06:49AM
Feb 2, 2026 07:00AM
Feb 2, 2026 07:00AM
Jan 13, 2026 10:59AM
Jan 9, 2026 07:02AM
Jan 9, 2026 07:00AM Aquestive Therapeutics Announces Regulatory Development for Anaphylm™ (dibutepinephrine) Sublingual Film and Provides Business Update
Nov 5, 2025 04:01PM
Nov 4, 2025 07:00AM
Nov 3, 2025 07:00AM
Oct 30, 2025 07:00AM
Oct 8, 2025 07:00AM
Oct 8, 2025 07:00AM
Sep 4, 2025 07:00AM Aquestive says FDA won't require advisory meeting for Anaphylm drug
Sep 4, 2025 07:00AM
Aug 26, 2025 08:07AM
Aug 14, 2025 06:28AM
Aug 14, 2025 06:28AM
Aug 14, 2025 06:01AM
Aug 14, 2025 06:00AM
Aug 11, 2025 04:01PM Aquestive Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
Jul 22, 2025 08:53AM

332,024 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All